A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia-Reference-Cited by-同舟云学术

A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia

Published:2007-12 Issue:6 Volume:1 Page:634-639
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Chastain Lisa M.,Bain Amy M.,Edwards Krystal L.,Bedimo Roger,Busti Anthony J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

2. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study;Tsiodras;Arch Intern Med,2000

3. Metabolic complications associated with HIV protease inhibitor therapy;Nolan;Drugs,2003

4. Third Report of the National Cholesterol Education Program on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults final report;Circulation,2004

5. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of ezetimibe in human immunodeficiency virus patients treated for hyperlipidaemia: a systematic review and meta-analysis;Infectious Diseases;2021-09-30

2. Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome and Lipodystrophy: Pathophysiology and Current Therapeutic Interventions;Journal of Endocrinology and Metabolism;2017

3. Drug therapies for HIV-related metabolic disorders;Expert Opinion on Pharmacotherapy;2016-05-30

4. Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients;Journal of Antimicrobial Chemotherapy;2016-02-03

5. Managing dyslipidemia in HIV/AIDS patients: challenges and solutions;HIV/AIDS - Research and Palliative Care;2014-12